Prevalence of Gestational Diabetes in Iran: A Systematic Review and Meta-analysis.

Q2 Medicine Medical Journal of the Islamic Republic of Iran Pub Date : 2023-07-24 eCollection Date: 2023-01-01 DOI:10.47176/mjiri.37.83

Sara Sadeghi, Seyed Reza Khatibi, Mehrsadat Mahdizadeh, Nooshin Peyman, Samira Zare Dorniani

{"title":"Prevalence of Gestational Diabetes in Iran: A Systematic Review and Meta-analysis.","authors":"Sara Sadeghi, Seyed Reza Khatibi, Mehrsadat Mahdizadeh, Nooshin Peyman, Samira Zare Dorniani","doi":"10.47176/mjiri.37.83","DOIUrl":null,"url":null,"abstract":"Background: Pregnant women who have gestational diabetes mellitus (GDM) are more prone to adverse pregnancy outcomes. We estimated the prevalence of GDM in Iran.Methods: Web of Science, Scopus, PubMed, Google Scholar, and Persian databases (SID, Magiran, Irandoc, and) were searched using the MeSH and non-MeSH terms in abstract, title, or keywords of articles until June 2021, with no limitation in time. Random effects models were applied to summarize the GDM prevalence in Iran. The obtained data were quantitatively analyzed to determine an effect size for each paper. The pooled effect size was introduced as prevalence and 95% confidence interval. Sensitivity analyses and subgroup analyses were done to determine heterogeneity. Publication bias was assessed by the classic fail-safe N and Egger test.Results: A total of 53 papers were considered for meta-analysis, involving 56,521 Iranians. The total GDM prevalence in Iran was 7.6% (95% CI, 6.1%-9.4%).Conclusion: This meta-analysis was the newest to estimate the GDM prevalence among Iranian women. Our results suggest a high prevalence of GDM in Iran, showing that Iran might have many GDM patients.","PeriodicalId":18361,"journal":{"name":"Medical Journal of the Islamic Republic of Iran","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10657259/pdf/","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medical Journal of the Islamic Republic of Iran","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.47176/mjiri.37.83","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 1

Abstract

Background: Pregnant women who have gestational diabetes mellitus (GDM) are more prone to adverse pregnancy outcomes. We estimated the prevalence of GDM in Iran.

Methods: Web of Science, Scopus, PubMed, Google Scholar, and Persian databases (SID, Magiran, Irandoc, and) were searched using the MeSH and non-MeSH terms in abstract, title, or keywords of articles until June 2021, with no limitation in time. Random effects models were applied to summarize the GDM prevalence in Iran. The obtained data were quantitatively analyzed to determine an effect size for each paper. The pooled effect size was introduced as prevalence and 95% confidence interval. Sensitivity analyses and subgroup analyses were done to determine heterogeneity. Publication bias was assessed by the classic fail-safe N and Egger test.

Results: A total of 53 papers were considered for meta-analysis, involving 56,521 Iranians. The total GDM prevalence in Iran was 7.6% (95% CI, 6.1%-9.4%).

Conclusion: This meta-analysis was the newest to estimate the GDM prevalence among Iranian women. Our results suggest a high prevalence of GDM in Iran, showing that Iran might have many GDM patients.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

妊娠期糖尿病在伊朗的患病率:一项系统回顾和荟萃分析。

背景:患有妊娠期糖尿病(GDM)的孕妇更容易发生不良妊娠结局。我们估计了GDM在伊朗的患病率。方法:检索Web of Science、Scopus、PubMed、Google Scholar和波斯数据库(SID、Magiran、Irandoc、and)，使用文章摘要、标题或关键词中的MeSH和非MeSH术语进行检索，截止日期为2021年6月，没有时间限制。采用随机效应模型对伊朗的GDM患病率进行了总结。对获得的数据进行定量分析，以确定每篇论文的效应大小。合并效应量作为患病率和95%置信区间引入。通过敏感性分析和亚组分析来确定异质性。发表偏倚通过经典的故障安全N和Egger检验进行评估。结果:共纳入53篇论文进行meta分析，涉及56521名伊朗人。伊朗GDM总患病率为7.6% (95% CI, 6.1%-9.4%)。结论:该荟萃分析是估计伊朗女性GDM患病率的最新研究。我们的研究结果表明，伊朗的GDM患病率很高，表明伊朗可能有许多GDM患者。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊